Oxidative Stress Assay Market: By Product (Instrument, Consumables, and Services), By Test Type (Indirect Assays, Antioxidant Capacity Assays, Enzyme Based Assays, and Reactive Oxygen Species Based Assays), By Technology Type (Enzyme-Linked Immunosorbent Assay (Elisa), Flow Cytometry, Chromatography, Microscopy, and Others), By Disease Type (Cardiovascular Disease, Chronic Obstructive Pulmonary Disease (COPD), and Cancer), and Geography

Oxidative Stress Assay Market size was estimated at USD 1,283.4 million in 2023 and is poised to grow at a CAGR of 8.7% from 2024 to 2030. The oxidative stress assay market is the global market for assays and techniques for measuring oxidative stress levels in biological samples. Oxidative stress occurs when there is an imbalance between free radicals (reactive oxygen species) and antioxidants in the body, leading to damage to cells, proteins, and DNA. This imbalance is implicated in various diseases including cancer, cardiovascular diseases, neurodegenerative disorders, and ageing. The upcoming years are likely to witness a notable expansion in the oxidative stress assay market. This growth is propelled by rising incidence of oxidative stress-related diseases, heightened research and development endeavours by pharmaceutical firms and research institutions, and technological innovations in assays for oxidative stress.

Additionally, supportive efforts by major industry players and governmental organizations to alleviate disease burdens are expected to spur research efforts, consequently boosting the global demand for oxidative stress assays. The anticipated rise in the oxidative stress assay market is fueled by the growing incidence of diseases correlated with oxidative stress, including cardiovascular diseases, respiratory conditions, oncological disorders, diabetes, and more. A study released by the Institute for Health Metrics and Evaluation in April 2023 revealed a global prevalence of approximately 454.6 million cases of chronic respiratory illnesses such as COPD, pneumoconiosis, asthma, and similar conditions. However, these instruments are equipped with advanced features and functionalities and thus are priced at a premium. For instance, a confocal microscope used in HCS can cost up to USD 250,000. Additionally, variability and complexity of oxidative stress biomarkers also acts as a restraint of the oxidative stress assay market.

Oxidative Stress Assay market Key Developments:

• In June 2022, Dojindo, Japan launched the ROS assay kit for photo-oxidation resistant DCFH-DA. DCFH-DA is widely used for reactive oxygen species detection.
• In February 2022, Invitae introduced FusionPlex Dx and LiquidPlex Dx in Europe. FusionPlex Dx is intended to be used as a CDx to aid in identifying patients diagnosed with NSCLC with ROS proto-oncogene 1, receptor tyrosine kinase (ROS1) fusions, and others for whom treatment with targeted therapy may be beneficial.